BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 15727862)

  • 1. Fluorosubstitution and 7-alkylation as prospective modifications of biologically active 6-aryl derivatives of tricyclic acyclovir and ganciclovir analogues.
    Ostrowski T; Golankiewicz B; De Clercq E; Balzarini J
    Bioorg Med Chem; 2005 Mar; 13(6):2089-96. PubMed ID: 15727862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and fluorescent properties of 6-(4-biphenylyl)-3,9-dihydro-9-oxo-5H-imidazo[1,2-a]purine analogues of acyclovir and ganciclovir.
    Goslinski T; Wenska G; Golankiewicz B; Balzarini J; De Clercq E
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):911-4. PubMed ID: 14565309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluorescent tricyclic analogues of acyclovir and ganciclovir. A structure-antiviral activity study.
    Golankiewicz B; Ostrowski T; Goslinski T; Januszczyk P; Zeidler J; Baranowski D; de Clercq E
    J Med Chem; 2001 Nov; 44(24):4284-7. PubMed ID: 11708929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pronounced cytostatic activity and bystander effect of a novel series of fluorescent tricyclic acyclovir and ganciclovir derivatives in herpes simplex virus thymidine kinase gene-transduced tumor cell lines.
    Balzarini J; Ostrowski T; Goslinski T; De Clercq E; Golankiewicz B
    Gene Ther; 2002 Sep; 9(17):1173-82. PubMed ID: 12170381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of strongly fluorescent tricyclic analogues of acyclovir and ganciclovir.
    Goslinski T; Golankiewicz B; De Clercq E; Balzarini J
    J Med Chem; 2002 Nov; 45(23):5052-7. PubMed ID: 12408716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superior cytostatic activity of the ganciclovir elaidic acid ester due to the prolonged intracellular retention of ganciclovir anabolites in herpes simplex virus type 1 thymidine kinase gene-transfected tumor cells.
    Balzarini J; Degrève B; Andrei G; Neyts J; Sandvold M; Myhren F; de Clercq E
    Gene Ther; 1998 Mar; 5(3):419-26. PubMed ID: 9614564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful kinase bypass with new acyclovir phosphoramidate prodrugs.
    McGuigan C; Derudas M; Bugert JJ; Andrei G; Snoeck R; Balzarini J
    Bioorg Med Chem Lett; 2008 Aug; 18(15):4364-7. PubMed ID: 18614365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
    Balzarini J; Bohman C; Walker RT; de Clercq E
    Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, 18F-radiolabelling and biological evaluations of C-6 alkylated pyrimidine nucleoside analogues.
    Raić-Malić S; Johayem A; Ametamey SM; Batinac S; De Clercq E; Folkers G; Scapozza L
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(11):1707-21. PubMed ID: 15598073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modifications on the heterocyclic base of ganciclovir, penciclovir, acyclovir - syntheses and antiviral properties.
    Chuchkov K; Chayrov R; Hinkov A; Todorov D; Shishkova K; Stankova IG
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):979-990. PubMed ID: 32312162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
    Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
    J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular uptake of thymidine and antiherpetic drugs for thymidine kinase-deficient mutants of herpes simplex virus type 1.
    Bae PK; Kim JH; Kim HS; Chung IK; Paik SG; Lee CK
    Antiviral Res; 2006 Jul; 70(3):93-104. PubMed ID: 16546268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of herpes simplex virus type 1 recombinant thymidine kinase and its application to a rapid antiviral sensitivity assay.
    Shiota T; Lixin W; Takayama-Ito M; Iizuka I; Ogata M; Tsuji M; Nishimura H; Taniguchi S; Morikawa S; Kurane I; Mizuguchi M; Saijo M
    Antiviral Res; 2011 Aug; 91(2):142-9. PubMed ID: 21669227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and synthesis of 3'-fluoropenciclovir analogues as antiviral agents.
    Choi MH; Lee CK; Kim HD
    Arch Pharm Res; 2010 Feb; 33(2):197-202. PubMed ID: 20195818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selection of HSV-1 TK gene-transfected murine mammary carcinoma cells resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and ganciclovir (GCV).
    Degrève B; De Clercq E; Balzarini J
    Gene Ther; 2000 Sep; 7(18):1543-52. PubMed ID: 11021592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
    J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of herpes simplex viruses selected in culture for resistance to penciclovir or acyclovir.
    Sarisky RT; Quail MR; Clark PE; Nguyen TT; Halsey WS; Wittrock RJ; O'Leary Bartus J; Van Horn MM; Sathe GM; Van Horn S; Kelly MD; Bacon TH; Leary JJ
    J Virol; 2001 Feb; 75(4):1761-9. PubMed ID: 11160674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metal complexes of acyclovir and its acetylated derivative on Herpes simplex virus 1 and Herpes simplex virus 2 replication.
    Varadinova T; Vilhelmova N; Badenas F; Terrón A; Fiol J; Garcia-Raso A; Genova P
    Acta Virol; 2005; 49(4):251-60. PubMed ID: 16402682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and susceptibility to antiviral agents of herpes simplex virus type 1 containing a unique thymidine kinase gene with an amber codon between the first and the second initiation codons.
    Saijo M; Suzutani T; Mizuta K; Kurane I; Morikawa S
    Arch Virol; 2008; 153(2):303-14. PubMed ID: 18066636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tricyclic nucleoside analogues as antiherpes agents.
    Golankiewicz B; Ostrowski T
    Antiviral Res; 2006 Sep; 71(2-3):134-40. PubMed ID: 16780965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.